About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PCCA Sets Industry Benchmark as First Supplier with USP Verified Excipient Compounding Bases

By: via GlobeNewswire

Houston, June 10, 2025 (GLOBE NEWSWIRE) -- PCCA, a leading supplier of pharmaceutical ingredients, announced today the U.S. Pharmacopeia (USP) has verified two of its proprietary compounding bases — LoxOral® and Anhydrous SuspendIt® — earning PCCA a recognized mark of independent quality assurance.

PCCA is the first FDA-registered supplier to complete the USP Ingredient Verification Program for Excipients for compounding bases, underscoring the company’s commitment to the highest industry standards and regulatory compliance. The USP Ingredient Verification Program for Excipients is a third-party, science-based process involving rigorous testing, manufacturing audits and quality control evaluations.

This distinction elevates PCCA’s products, offering a clear quality differentiator to complement the already highly desirable functional attributes of its bases. USP Verification Programs are widely recognized as the trusted quality benchmark for assessing the quality of active pharmaceutical ingredients, excipients, dietary supplements and dietary ingredients. 

“This validation milestone demonstrates our ‘Quality without Compromise’ core value in action,” said PCCA CEO Gus Bassani, PharmD. “Confirmation of quality through independent verification reinforces our promise to pharmacies and patients alike. By undertaking this approach, we help our members compound with confidence.”

USP verified two of PCCA’s most used bases: LoxOral®, an all-in-one compounding excipient designed for oral capsules, facilitating the easy mixing of diverse active pharmaceutical ingredients, and Anhydrous SuspendIt®, a specially designed, water-free oral base that mixes easily with liquids and offers improved taste and broader applications.

USP’s verification of these bases exemplifies PCCA’s focus on providing pharmacies with assurance of the quality, purity and consistency of its products. PCCA also invests heavily in research and development to create unique, patented bases to enhance therapeutic outcomes.

“We proactively pursued and invested in this program to verify the quality of our bases, even though regulations do not require it,” Bassani said. “And we will be pursuing this verification for additional proprietary bases of ours.”

Holly Chang, Vice President of Technical Services at USP, shared, “USP is pleased to recognize PCCA’s successful completion of the Ingredient Verification Program for Excipients. This accomplishment demonstrates a commitment to quality, enabling manufacturers of compounded pharmaceutical products to easily identify PCCA’s LoxOral® and Anhydrous SuspendIt® bases as trusted quality excipients.”

Moving forward, Bassani said PCCA remains focused on providing independent compounding pharmacies and health systems with quality products, expert guidance and innovative approaches to delivering personalized medicine.

ABOUT PCCA
PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Learn more at pccarx.com.

Attachment 


Kim Speairs, APR, MBA
PCCA
817.729.5064
kspeairs@pccarx.com

More News

View More
FICO’s Big Dip Could Be the Best Buying Chance of the Year
Via MarketBeat
Tickers EFX FICO
D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Via MarketBeat
Tickers QBTS RGTI
Datavault: A Speculative AI Play, But Beware of Volatility
Via MarketBeat
Topics Artificial Intelligence
Tickers DVLT IBM SCLX
Traders Are Piling Into Suncor Call Options—Should You?
Via MarketBeat
Topics World Trade
Tickers SU
Delta Air Lines Stock Looks Ready to Fly to New Highs
Via MarketBeat
Tickers DAL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.